Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2025)
Historic Debt Ratio for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.71.
- Amneal Pharmaceuticals' Debt Ratio rose 334.55% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 334.55%. This contributed to the annual value of 0.68 for FY2024, which is 774.57% down from last year.
- As of Q3 2025, Amneal Pharmaceuticals' Debt Ratio stood at 0.71, which was up 334.55% from 0.71 recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Debt Ratio registered a high of 0.74 during Q1 2024, and its lowest value of 0.67 during Q2 2022.
- Over the past 5 years, Amneal Pharmaceuticals' median Debt Ratio value was 0.7 (recorded in 2021), while the average stood at 0.7.
- Per our database at Business Quant, Amneal Pharmaceuticals' Debt Ratio skyrocketed by 765.74% in 2023 and then plummeted by 774.57% in 2024.
- Quarter analysis of 5 years shows Amneal Pharmaceuticals' Debt Ratio stood at 0.69 in 2021, then increased by 0.81% to 0.7 in 2022, then grew by 5.82% to 0.74 in 2023, then fell by 7.75% to 0.68 in 2024, then grew by 4.92% to 0.71 in 2025.
- Its last three reported values are 0.71 in Q3 2025, 0.71 for Q2 2025, and 0.73 during Q1 2025.